RH-34

A31AED225O, 3-[2-[[(2-Methoxyphenyl)methyl]amino]ethyl]-2,4(1H,3H)-quinazolinedione, 3-(2-(2-Methoxybenzylamino)ethyl)-1H-quinazoline-2,4-dione, 2,4(1H,3H)-Quinazolinedione, 3-(2-(((2-methoxyphenyl)methyl)amino)ethyl)-, 3-[2-(2-methoxybenzylamino)ethyl]-1H-quinazoline-2,4-dione, 3-(2-(((2-Methoxyphenyl)methyl)amino)ethyl)-2,4(1H,3H)-quinazolinedione, RefChem:1066451, 3-(2-((2-Methoxybenzyl)amino)ethyl)quinazoline-2,4(1H,3H)-dione, RH-34, 3-[2-[(2-methoxyphenyl)methylamino]ethyl]-1H-quinazoline-2,4-dione, MFCD22573566, UNII-A31AED225O, 3-[2-[[(2-Methoxyphenyl)Methyl]aMino]ethyl]-2,4(1H,3 H)-quinazolinedione, 5-HT2A receptor agonist-6, orb2814434, SCHEMBL10321390, SCHEMBL29390721, SCHEMBL31498034, DTXSID80434687, AKOS016010681, DS-5691, FM138069, HY-19950, DB-112439, CS-0017134, NS00017526, A11281, Q7276696, 3-(2-{[(2-Methoxyphenyl)methyl]amino}ethyl)quinazoline-2,4(1H,3H)-dione,